Damora Therapeutics’ Execs Grant Massive Options, Betting on Stock Surge Amid 632% YTD Gain
Damora Therapeutics insiders receive large option grants, showing confidence in future growth; investors should watch upcoming milestones and potential dilution.
3 minutes to read

